GE Healthcare’s Discovery NM630 – for quicker, lower dose imaging – has just been approved by the Food and Drug Administration. This new system for disease detection and diagnosis is a SPECT scan – or ...

CHICAGO--(BUSINESS WIRE)--GE HealthCare today announced CE Mark for its new StarGuide™ GX system, i a new digital 4D SPECT/CT designed with excellent precision, clinical efficiency and impressive ...

NEW ORLEANS, La.-- (BUSINESS WIRE)--GE Healthcare today presented the results of a randomized study analyzing the effect of DaTscan™ (Ioflupane I 123 Injection) SPECT imaging in a group of adult ...

The FINANCIAL — At the Society of Nuclear Medicine this year, GE Healthcare is introducing the latest addition to its Nuclear Medicine 600 series with a new performance SPECT/CT system—the Optima ...

GE HealthCare has announced that the Food and Drug Administration has granted clearance for its Aurora nuclear medicine system and Clarify DL, an AI-powered deep learning image reconstruction ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance to GE HealthCare's Aurora nuclear medicine system and Clarify DL. The company's dual-head single photon emission computed ...

Single-photon emission computerized tomography (SPECT/CT) systems are a key tool to diagnose and monitor diseases, but for the past sixty years the technology has remained more or less the same. This ...

Evercare Hospital Lekki, a state-of-the-art medical facility located in Lagos, has raised the bar in clinical excellence and diagnostic versatility with the procurement and installation of the GE ...

StarGuide GX i empowers personalized care and research innovation as nuclear medicine expands into new applications The system doubles volume sensitivity, ii maintains high resolution and enables ...